TR199501082A2 - Pharmaceutical formulations. - Google Patents

Pharmaceutical formulations.

Info

Publication number
TR199501082A2
TR199501082A2 TR95/01082A TR9501082A TR199501082A2 TR 199501082 A2 TR199501082 A2 TR 199501082A2 TR 95/01082 A TR95/01082 A TR 95/01082A TR 9501082 A TR9501082 A TR 9501082A TR 199501082 A2 TR199501082 A2 TR 199501082A2
Authority
TR
Turkey
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
TR95/01082A
Other languages
Turkish (tr)
Inventor
Patrick John Crowley
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9417953A external-priority patent/GB9417953D0/en
Priority claimed from GBGB9503752.9A external-priority patent/GB9503752D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR199501082A2 publication Critical patent/TR199501082A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR95/01082A 1994-09-03 1995-08-31 Pharmaceutical formulations. TR199501082A2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9417953A GB9417953D0 (en) 1994-09-03 1994-09-03 Pharmaceutical formulations
GBGB9503752.9A GB9503752D0 (en) 1995-02-24 1995-02-24 Pharmaceutical formulations
US46044195A 1995-06-02 1995-06-02

Publications (1)

Publication Number Publication Date
TR199501082A2 true TR199501082A2 (en) 1996-06-21

Family

ID=27267365

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01082A TR199501082A2 (en) 1994-09-03 1995-08-31 Pharmaceutical formulations.

Country Status (8)

Country Link
EP (1) EP0782443A1 (en)
JP (1) JPH10505595A (en)
AU (1) AU3471995A (en)
DZ (1) DZ1926A1 (en)
IL (1) IL115125A0 (en)
MA (1) MA23663A1 (en)
TR (1) TR199501082A2 (en)
WO (1) WO1996007408A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR004510A1 (en) 1995-09-07 1998-12-16 Smithkline Beecham Plc COMPOSITIONS INCLUDING AMOXICILLIN AND CLAVULANATE, PROCEDURES FOR ITS PREPARATION AND THE USE OF COMPOSITIONS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
DE69815833T2 (en) * 1997-02-14 2004-05-19 Laboratoire Glaxosmithkline S.A.S. MEDICAL PREPARATIONS CONTAINING AMOXICILLIN AND CLAVULANATE
US6706290B1 (en) 1998-07-06 2004-03-16 Olvai E. Kajander Methods for eradication of nanobacteria
WO2000001238A1 (en) * 1998-07-06 2000-01-13 Kajander E Olavi Methods for eradication of nanobacteria
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US8614315B2 (en) * 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
TR201000688A2 (en) 2010-01-29 2011-08-22 B�Lg�� Mahmut Effervescent formulations containing cefaclor and clavulanic acid as active ingredient.
WO2011152809A2 (en) * 2010-06-03 2011-12-08 Bilgic Mahmut Effervescent formulations comprising cephalosporin and clavulanic acid

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002312B1 (en) * 1977-11-26 1982-02-03 Beecham Group Plc Derivatives of clavulanic acid and pharmaceutical compositions containing them
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
DE69425131T2 (en) * 1993-01-22 2001-03-15 Smithkline Beecham Plc USE OF CLAVULIC ACID AND AN ANTIBIOTIC FOR TREATING INFECTIONS

Also Published As

Publication number Publication date
WO1996007408A1 (en) 1996-03-14
IL115125A0 (en) 1995-12-31
DZ1926A1 (en) 2002-02-17
JPH10505595A (en) 1998-06-02
AU3471995A (en) 1996-03-27
EP0782443A1 (en) 1997-07-09
MA23663A1 (en) 1996-04-01

Similar Documents

Publication Publication Date Title
BR9610153A (en) Pharmaceutical formulations
BR9611626A (en) Pharmaceutical formulations
TR199901077A3 (en) Pharmaceutical formulations.
DE69530325D1 (en) AEROSOL DRUG FORMULATIONS
FI971279A (en) Drug
DZ2026A1 (en) Vaccinating compositions.
DZ2055A1 (en) Vaccinating compositions.
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
NO954486D0 (en) Pharmaceutical formulation basis
DZ1835A1 (en) New formulations.
ID18352A (en) PHARMACEUTICAL COMPOSITIONS
TR199501082A2 (en) Pharmaceutical formulations.
ID16781A (en) PHARMACEUTICAL FORMULATIONS
BR9507768A (en) Pharmaceutical composition
ITMI941169A0 (en) PHARMACEUTICAL FORMULATIONS
PT941100E (en) PHARMACEUTICAL COMPOSITIONS
ITMI942166A0 (en) PHARMACEUTICAL COMPOSITIONS MIORELAXANTS
FI951155A0 (en) Pharmaceutical preparation
TR199601018A1 (en) Pharmaceutical compounds.
ITMI962628A0 (en) PHARMACEUTICAL COMPOSITION
FI962738A0 (en) Pharmaceutical compositions
FI934317A0 (en) PHARMACEUTICAL SAMMANSAETTNINGAR, VILKA INNEHAOLLER EJ-JONISKA YTAKTIVA AEMNEN
TR199500776A2 (en) Pharmaceutical compositions.
SE9404467D0 (en) Drug formulations
SE9502453D0 (en) Drug formulations